TY - JOUR
AU - T. Bommersbach
AU - M. Justen
AU - A. M. Bunting
AU - M. C. Funaro
AU - E. L. Winstanley
AU - P. J. Joudrey
A1 - 
AD - Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA. Electronic address: tanner.bommersbach@gmail.com.;Yale University School of Medicine, New Haven, CT, USA.;Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.;Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, USA.;Department of Behavioral Medicine and Psychiatry, School of Medicine, West Virginia University, Morgantown, WV, USA; Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA.;Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA.
AN - 36563489
BT - Int J Drug Policy
C5 - Opioids & Substance Use;Healthcare Disparities
DA - Feb
DO - 10.1016/j.drugpo.2022.103931
DP - NLM
ET - 20221221
JF - Int J Drug Policy
LA - eng
PY - 2023
SN - 0955-3959
SP - 103931
ST - Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review
T1 - Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review
T2 - Int J Drug Policy
TI - Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review
U1 - Opioids & Substance Use;Healthcare Disparities
U3 - 10.1016/j.drugpo.2022.103931
VL - 112
VO - 0955-3959
Y1 - 2023
ER -